Mirum Pharmaceuticals (MIRM) Highlights Data Demonstrating Impact of LIVMARLI streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Six-year natural history comparison with maralixibat demonstrates event-free and transplant-free survival in patients with Alagille syndrome Maralixibat data highlighting predictors of event-free
Eight abstracts accepted, including three oral presentations Maralixibat data highlighting predictors of event-free survival in patients with Alagille syndrome nominated for prestigious Alex Mowat
- Eight abstracts accepted, including three oral presentations
- Maralixibat data highlighting predictors of event-free survival in patients with Alagille syndrome nominated for prestigious Alex. | June 13, 2022
Mirum Pharmaceuticals, Inc (MIRM) to Showcase LIVMARLI Data at EASL and ESPGHAN Annual Congresses streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.